Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79


Exploring the Bi-Directional Association between Tobacco and E-Cigarette Use among Youth in Canada.

Aleyan S, Gohari MR, Cole AG, Leatherdale ST.

Int J Environ Res Public Health. 2019 Nov 1;16(21). pii: E4256. doi: 10.3390/ijerph16214256.


Author Correction: The mid-developmental transition and the evolution of animal body plans.

Levin M, Anavy L, Cole AG, Winter E, Mostov N, Khair S, Senderovich N, Kovalev E, Silver DH, Feder M, Fernandez-Valverde SL, Nakanishi N, Simmons D, Simakov O, Larsson T, Liu SY, Jerafi-Vider A, Yaniv K, Ryan JF, Martindale MQ, Rink JC, Arendt D, Degnan SM, Degnan BM, Hashimshony T, Yanai I.

Nature. 2019 Nov;575(7782):E3. doi: 10.1038/s41586-019-1698-x.


Exploring the association between E-cigarette retailer proximity and density to schools and youth E-cigarette use.

Cole AG, Aleyan S, Leatherdale ST.

Prev Med Rep. 2019 May 30;15:100912. doi: 10.1016/j.pmedr.2019.100912. eCollection 2019 Sep.


Addicts and Admits: Metonymy in Medical Students' Reflective Writing.

Camp ME, Cole AG, Sadler JZ.

Teach Learn Med. 2020 Jan-Mar;32(1):23-33. doi: 10.1080/10401334.2019.1607742. Epub 2019 May 9.


Youth consumption of alcohol mixed with energy drinks in Canada: Assessing the role of energy drinks.

Doggett A, Qian W, Cole AG, Leatherdale ST.

Prev Med Rep. 2019 Apr 5;14:100865. doi: 10.1016/j.pmedr.2019.100865. eCollection 2019 Jun.


Offers of Cigarettes and E-Cigarettes Among High School Students: A Population Study from California.

Cole AG, Cummins SE, Zhu SH.

Int J Environ Res Public Health. 2019 Mar 30;16(7). pii: E1143. doi: 10.3390/ijerph16071143.


Assessing the strength of secondary school tobacco policies of schools in the COMPASS study and the association to student smoking behaviours.

Cole AG, Aleyan S, Qian W, Leatherdale ST.

Can J Public Health. 2019 Apr;110(2):236-243. doi: 10.17269/s41997-019-00178-4. Epub 2019 Jan 31.


School start time changes in the COMPASS study: associations with youth sleep duration, physical activity, and screen time.

Patte KA, Qian W, Cole AG, Faulkner G, Chaput JP, Carson V, Leatherdale ST.

Sleep Med. 2019 Apr;56:16-22. doi: 10.1016/j.sleep.2018.09.020. Epub 2018 Oct 12.


From Good to Great: The Role of Performance Coaching in Enhancing Tobacco-Dependence Treatment Rates.

Papadakis S, Cole AG, Reid RD, Assi R, Gharib M, Tulloch HE, Mullen KA, Wells G, Pipe AL.

Ann Fam Med. 2018 Nov;16(6):498-506. doi: 10.1370/afm.2312.


Synthesis and SAR studies of novel benzodiazepinedione-based inhibitors of Clostridium difficile (C. difficile) toxin B (TcdB).

Letourneau JJ, Stroke IL, Hilbert DW, Cole AG, Sturzenbecker LJ, Marinelli BA, Quintero JG, Sabalski J, Li Y, Ma L, Pechik I, Stein PD, Webb ML.

Bioorg Med Chem Lett. 2018 Dec 15;28(23-24):3601-3605. doi: 10.1016/j.bmcl.2018.10.047. Epub 2018 Oct 29.


Identifying behavioural characteristics of tobacco product and e-cigarette use clusters: A repeat cross-sectional analysis.

Cole AG, Chaurasia A, Kennedy RD, Leatherdale ST.

Addict Behav. 2019 Mar;90:77-84. doi: 10.1016/j.addbeh.2018.10.026. Epub 2018 Oct 19.


The gene regulatory program of Acrobeloides nanus reveals conservation of phylum-specific expression.

Schiffer PH, Polsky AL, Cole AG, Camps JIR, Kroiher M, Silver DH, Grishkevich V, Anavy L, Koutsovoulos G, Hashimshony T, Yanai I.

Proc Natl Acad Sci U S A. 2018 Apr 24;115(17):4459-4464. doi: 10.1073/pnas.1720817115. Epub 2018 Apr 6.


Preclinical Profile of AB-423, an Inhibitor of Hepatitis B Virus Pregenomic RNA Encapsidation.

Mani N, Cole AG, Phelps JR, Ardzinski A, Cobarrubias KD, Cuconati A, Dorsey BD, Evangelista E, Fan K, Guo F, Guo H, Guo JT, Harasym TO, Kadhim S, Kultgen SG, Lee ACH, Li AHL, Long Q, Majeski SA, Mao R, McClintock KD, Reid SP, Rijnbrand R, Snead NM, Micolochick Steuer HM, Stever K, Tang S, Wang X, Zhao Q, Sofia MJ.

Antimicrob Agents Chemother. 2018 May 25;62(6). pii: e00082-18. doi: 10.1128/AAC.00082-18. Print 2018 Jun.


Exploring the Predictive Validity of the Susceptibility to Smoking Construct for Tobacco Cigarettes, Alternative Tobacco Products, and E-Cigarettes.

Cole AG, Kennedy RD, Chaurasia A, Leatherdale ST.

Nicotine Tob Res. 2019 Feb 18;21(3):323-330. doi: 10.1093/ntr/ntx265.


Youth sleep durations and school start times: a cross-sectional analysis of the COMPASS study.

Patte KA, Cole AG, Qian W, Leatherdale ST.

Sleep Health. 2017 Dec;3(6):432-436. doi: 10.1016/j.sleh.2017.07.011. Epub 2017 Sep 22.


Electronic cigarette use and smoking initiation among youth: a longitudinal cohort study.

Hammond D, Reid JL, Cole AG, Leatherdale ST.

CMAJ. 2017 Oct 30;189(43):E1328-E1336. doi: 10.1503/cmaj.161002.


Changing the Smoking Trajectory: Evaluating the Impact of School-Based Tobacco Interventions on Changes to Susceptibility to Future Smoking.

Cole AG, Qian W, Leatherdale ST.

Int J Environ Res Public Health. 2017 Oct 5;14(10). pii: E1182. doi: 10.3390/ijerph14101182.


Modulators of HBV capsid assembly as an approach to treating hepatitis B virus infection.

Cole AG.

Curr Opin Pharmacol. 2016 Oct;30:131-137. doi: 10.1016/j.coph.2016.08.004. Review.


Analyses of Sox-B and Sox-E Family Genes in the Cephalopod Sepia officinalis: Revealing the Conserved and the Unusual.

Focareta L, Cole AG.

PLoS One. 2016 Jun 22;11(6):e0157821. doi: 10.1371/journal.pone.0157821. eCollection 2016.


Increasing Rates of Tobacco Treatment Delivery in Primary Care Practice: Evaluation of the Ottawa Model for Smoking Cessation.

Papadakis S, Cole AG, Reid RD, Coja M, Aitken D, Mullen KA, Gharib M, Pipe AL.

Ann Fam Med. 2016 May;14(3):235-43. doi: 10.1370/afm.1909.


The mid-developmental transition and the evolution of animal body plans.

Levin M, Anavy L, Cole AG, Winter E, Mostov N, Khair S, Senderovich N, Kovalev E, Silver DH, Feder M, Fernandez-Valverde SL, Nakanishi N, Simmons D, Simakov O, Larsson T, Liu SY, Jerafi-Vider A, Yaniv K, Ryan JF, Martindale MQ, Rink JC, Arendt D, Degnan SM, Degnan BM, Hashimshony T, Yanai I.

Nature. 2016 Mar 31;531(7596):637-641. doi: 10.1038/nature16994. Epub 2016 Feb 17. Erratum in: Nature. 2019 Nov;575(7782):E3.


Effectiveness of performance coaching for enhancing rates of smoking cessation treatment delivery by primary care providers: Study protocol for a cluster randomized controlled trial.

Papadakis S, Pipe AL, Reid RD, Tulloch H, Mullen KA, Assi R, Cole AG, Wells G.

Contemp Clin Trials. 2015 Nov;45(Pt B):184-190. doi: 10.1016/j.cct.2015.08.013. Epub 2015 Sep 5.


Use of Conventional and Alternative Tobacco and Nicotine Products Among a Sample of Canadian Youth.

Czoli CD, Hammond D, Reid JL, Cole AG, Leatherdale ST.

J Adolesc Health. 2015 Jul;57(1):123-5. doi: 10.1016/j.jadohealth.2015.03.006. Epub 2015 Apr 28.


Roll-your-own tobacco use among Canadian youth: current prevalence and changes in youth smoking "rollies" since 2008.

Cole AG, Leatherdale ST, Rynard VL.

Chronic Dis Inj Can. 2014 Nov;34(4):263-9. English, French.


Characterization of homeobox genes reveals sophisticated regionalization of the central nervous system in the European cuttlefish Sepia officinalis.

Focareta L, Sesso S, Cole AG.

PLoS One. 2014 Oct 6;9(10):e109627. doi: 10.1371/journal.pone.0109627. eCollection 2014.


Determinants of arterial stiffness in COPD.

Bhatt SP, Cole AG, Wells JM, Nath H, Watts JR, Cockcroft JR, Dransfield MT.

BMC Pulm Med. 2014 Jan 4;14:1. doi: 10.1186/1471-2466-14-1.


Pattern and process during sea urchin gut morphogenesis: the regulatory landscape.

Annunziata R, Perillo M, Andrikou C, Cole AG, Martinez P, Arnone MI.

Genesis. 2014 Mar;52(3):251-68. doi: 10.1002/dvg.22738. Epub 2014 Jan 17. Review.


An examination of different smoking patterns among Canadian youth: new insight for tobacco control programming.

Cole AG, Leatherdale ST, Burkhalter R.

Addict Behav. 2013 Mar;38(3):1610-5. doi: 10.1016/j.addbeh.2012.10.004. Epub 2012 Oct 8.


Aminopurine based JNK inhibitors for the prevention of ischemia reperfusion injury.

Krenitsky VP, Delgado M, Nadolny L, Sahasrabudhe K, Ayala L, Clareen SS, Hilgraf R, Albers R, Kois A, Hughes K, Wright J, Nowakowski J, Sudbeck E, Ghosh S, Bahmanyar S, Chamberlain P, Muir J, Cathers BE, Giegel D, Xu L, Celeridad M, Moghaddam M, Khatsenko O, Omholt P, Katz J, Pai S, Fan R, Tang Y, Shirley MA, Benish B, Blease K, Raymon H, Bhagwat S, Henderson I, Cole AG, Bennett B, Satoh Y.

Bioorg Med Chem Lett. 2012 Feb 1;22(3):1427-32. doi: 10.1016/j.bmcl.2011.12.028. Epub 2011 Dec 11.


Minimizing pharmacodynamic interactions of high doses of lacosamide.

Edwards HB, Cole AG, Griffiths AS, Lin B, Bean A, Krauss GL.

Acta Neurol Scand. 2012 Apr;125(4):228-33. doi: 10.1111/j.1600-0404.2011.01619.x. Epub 2011 Nov 10.


Small molecule chemokine mimetics suggest a molecular basis for the observation that CXCL10 and CXCL11 are allosteric ligands of CXCR3.

Nedjai B, Li H, Stroke IL, Wise EL, Webb ML, Merritt JR, Henderson I, Klon AE, Cole AG, Horuk R, Vaidehi N, Pease JE.

Br J Pharmacol. 2012 Jun;166(3):912-23. doi: 10.1111/j.1476-5381.2011.01660.x.


Discovery of 2-aminoimidazopyridine adenosine A(2A) receptor antagonists.

McGuinness BF, Cole AG, Dong G, Brescia MR, Shao Y, Henderson I, Rokosz LL, Stauffer TM, Mannava N, Kimble EF, Hicks C, White N, Wines PG, Quadros E.

Bioorg Med Chem Lett. 2010 Nov 15;20(22):6845-9. doi: 10.1016/j.bmcl.2010.08.064. Epub 2010 Aug 19.


Identification and optimization of novel 2-(4-oxo-2-aryl-quinazolin-3(4H)-yl)acetamide vasopressin V3 (V1b) receptor antagonists.

Letourneau JJ, Riviello CM, Li H, Cole AG, Ho KK, Zanetakos HA, Desai H, Zhao J, Auld DS, Napier SE, Thomson FJ, Goan KA, Morphy JR, Ohlmeyer MH, Webb ML.

Bioorg Med Chem Lett. 2010 Sep 15;20(18):5394-7. doi: 10.1016/j.bmcl.2010.07.118. Epub 2010 Aug 1.


Selective functional inhibition of JAK-3 is sufficient for efficacy in collagen-induced arthritis in mice.

Lin TH, Hegen M, Quadros E, Nickerson-Nutter CL, Appell KC, Cole AG, Shao Y, Tam S, Ohlmeyer M, Wang B, Goodwin DG, Kimble EF, Quintero J, Gao M, Symanowicz P, Wrocklage C, Lussier J, Schelling SH, Hewet AG, Xuan D, Krykbaev R, Togias J, Xu X, Harrison R, Mansour T, Collins M, Clark JD, Webb ML, Seidl KJ.

Arthritis Rheum. 2010 Aug;62(8):2283-93. doi: 10.1002/art.27536.


2-Benzimidazolyl-9-(chroman-4-yl)-purinone derivatives as JAK3 inhibitors.

Cole AG, Bohnstedt AC, Paradkar V, Kingsbury C, Quintero JG, Park H, Lu Y, You M, Neagu I, Diller DJ, Letourneau JJ, Shao Y, James RA, Riviello CM, Ho KK, Lin TH, Wang B, Appell KC, Sills M, Quadros E, Kimble EF, Ohlmeyer MH, Webb ML.

Bioorg Med Chem Lett. 2009 Dec 1;19(23):6788-92. doi: 10.1016/j.bmcl.2009.09.080. Epub 2009 Sep 25.


ZOONET: perspectives on the evolution of animal form. Meeting report.

Fischer AH, Arboleda E, Egger B, Hilbrant M, McGregor AP, Cole AG, Daley AC.

J Exp Zool B Mol Dev Evol. 2009 Nov 15;312(7):679-85. doi: 10.1002/jez.b.21294.


Orally bioavailable, liver-selective stearoyl-CoA desaturase (SCD) inhibitors.

Koltun DO, Vasilevich NI, Parkhill EQ, Glushkov AI, Zilbershtein TM, Mayboroda EI, Boze MA, Cole AG, Henderson I, Zautke NA, Brunn SA, Chu N, Hao J, Mollova N, Leung K, Chisholm JW, Zablocki J.

Bioorg Med Chem Lett. 2009 Jun 1;19(11):3050-3. doi: 10.1016/j.bmcl.2009.04.004. Epub 2009 Apr 8.


Reciprocal responsiveness to interleukin-12 and interferon-alpha specifies human CD8+ effector versus central memory T-cell fates.

Ramos HJ, Davis AM, Cole AG, Schatzle JD, Forman J, Farrar JD.

Blood. 2009 May 28;113(22):5516-25. doi: 10.1182/blood-2008-11-188458. Epub 2009 Mar 18.


Fluorescent in situ hybridization reveals multiple expression domains for SpBrn1/2/4 and identifies a unique ectodermal cell type that co-expresses the ParaHox gene SpLox.

Cole AG, Arnone MI.

Gene Expr Patterns. 2009 Jun;9(5):324-8. doi: 10.1016/j.gep.2009.02.005. Epub 2009 Feb 27.


Novel, potent, selective, and metabolically stable stearoyl-CoA desaturase (SCD) inhibitors.

Koltun DO, Parkhill EQ, Vasilevich NI, Glushkov AI, Zilbershtein TM, Ivanov AV, Cole AG, Henderson I, Zautke NA, Brunn SA, Mollova N, Leung K, Chisholm JW, Zablocki J.

Bioorg Med Chem Lett. 2009 Apr 1;19(7):2048-52. doi: 10.1016/j.bmcl.2009.02.019. Epub 2009 Feb 8.


Synthesis and SAR studies of trisubstituted purinones as potent and selective adenosine A2A receptor antagonists.

Shao Y, Cole AG, Brescia MR, Qin LY, Duo J, Stauffer TM, Rokosz LL, McGuinness BF, Henderson I.

Bioorg Med Chem Lett. 2009 Mar 1;19(5):1399-402. doi: 10.1016/j.bmcl.2009.01.042. Epub 2009 Jan 19.


Two ParaHox genes, SpLox and SpCdx, interact to partition the posterior endoderm in the formation of a functional gut.

Cole AG, Rizzo F, Martinez P, Fernandez-Serra M, Arnone MI.

Development. 2009 Feb;136(4):541-9. doi: 10.1242/dev.029959. Epub 2009 Jan 14.


Synthesis of 2-amino-5-benzoyl-4-(2-furyl)thiazoles as adenosine A(2A) receptor antagonists.

Cole AG, Stauffer TM, Rokosz LL, Metzger A, Dillard LW, Zeng W, Henderson I.

Bioorg Med Chem Lett. 2009 Jan 15;19(2):378-81. doi: 10.1016/j.bmcl.2008.11.066. Epub 2008 Nov 24.


Sulfonamido-aryl ethers as bradykinin B1 receptor antagonists.

Cole AG, Metzger A, Brescia MR, Qin LY, Appell KC, Brain CT, Hallett A, Ganju P, Denholm AA, Wareing JR, Ritchie TJ, Drake GM, Bevan SJ, MacGloinn A, McBryde A, Patel V, Oakley PJ, Nunez X, Gstach H, Schneider P, Baldwin JJ, Dolle RE, McDonald E, Henderson I.

Bioorg Med Chem Lett. 2009 Jan 1;19(1):119-22. doi: 10.1016/j.bmcl.2008.11.005. Epub 2008 Nov 6.


Synthesis of (3,4-dimethoxyphenoxy)alkylamino acetamides as orexin-2 receptor antagonists.

Cole AG, Stroke IL, Qin LY, Hussain Z, Simhadri S, Brescia MR, Waksmunski FS, Strohl B, Tellew JE, Williams JP, Saunders J, Appell KC, Henderson I, Webb ML.

Bioorg Med Chem Lett. 2008 Oct 15;18(20):5420-3. doi: 10.1016/j.bmcl.2008.09.038. Epub 2008 Sep 12.


Cartilage differentiation in cephalopod molluscs.

Cole AG, Hall BK.

Zoology (Jena). 2009;112(1):2-15. doi: 10.1016/j.zool.2008.01.003. Epub 2008 Aug 22.


Identification and characterization of small-molecule inhibitors of Tie2 kinase.

Liu J, Lin TH, Cole AG, Wen R, Zhao L, Brescia MR, Jacob B, Hussain Z, Appell KC, Henderson I, Webb ML.

FEBS Lett. 2008 Mar 5;582(5):785-91. doi: 10.1016/j.febslet.2008.02.003. Epub 2008 Feb 11.


Discovery and preliminary evaluation of 5-(4-phenylbenzyl)oxazole-4-carboxamides as prostacyclin receptor antagonists.

Brescia MR, Rokosz LL, Cole AG, Stauffer TM, Lehrach JM, Auld DS, Henderson I, Webb ML.

Bioorg Med Chem Lett. 2007 Mar 1;17(5):1211-5. Epub 2006 Dec 12.


Supplemental Content

Support Center